What is the recommended antibiotic for bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic for Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for adults with acute bacterial sinusitis, due to increasing prevalence of β-lactamase-producing organisms (H. influenzae and M. catarrhalis). 1

Confirm Bacterial Sinusitis Before Prescribing

Before initiating antibiotics, ensure the patient meets one of three diagnostic criteria 2, 1:

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure, or cough) 2
  • Severe symptoms for ≥3 consecutive days (fever ≥39°C with purulent nasal discharge and facial pain) 2
  • "Double sickening" - worsening symptoms after initial improvement from a viral upper respiratory infection 2

Critical caveat: 98-99.5% of acute rhinosinusitis is viral and resolves spontaneously within 7-10 days without antibiotics—do not prescribe antibiotics for symptoms lasting <10 days unless severe features are present. 2

First-Line Antibiotic Selection

For Most Adults

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line choice over plain amoxicillin, given that 20-30% of H. influenzae and nearly 100% of M. catarrhalis produce β-lactamase. 1, 3 The clavulanate component provides essential coverage against these β-lactamase-producing organisms. 2

Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) remains acceptable only for uncomplicated cases without recent antibiotic exposure. 2

For Pediatric Patients

  • Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses for children without recent antibiotic use 2, 4
  • High-risk children (age <2 years, daycare attendance, antibiotics within past 4-6 weeks, or high local resistance): High-dose amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 2, 4

Treatment Duration

5-10 days of therapy is sufficient for most cases, with comparable efficacy to longer courses and fewer adverse effects. 2, 5 Most guidelines recommend treating until symptom-free for 7 days, typically totaling 10-14 days. 2

Penicillin-Allergic Patients

Non-Severe Allergy (Rash, Mild Reactions)

Second- or third-generation cephalosporins are safe and effective 2, 1:

  • Cefuroxime-axetil (second-generation) 2
  • Cefpodoxime-proxetil or cefdinir (third-generation, with superior activity against H. influenzae) 2, 3

The risk of cross-reactivity between penicillins and second/third-generation cephalosporins is negligible. 2

Severe Type I Hypersensitivity (Anaphylaxis)

Levofloxacin 500 mg once daily for 10-14 days or moxifloxacin 400 mg once daily for 10 days are appropriate alternatives, providing 90-92% predicted clinical efficacy. 2, 6

Critical pitfall: Azithromycin and other macrolides should NOT be used as first-line therapy due to resistance rates of 20-25% for both S. pneumoniae and H. influenzae. 2, 4

Second-Line Treatment for Treatment Failure

If no improvement occurs within 72 hours (pediatrics) or 3-5 days (adults), reassess the diagnosis and switch antibiotics 2, 1:

  • High-dose amoxicillin-clavulanate (if not already used): 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for children; 2 g amoxicillin every 12 hours for adults 2
  • Respiratory fluoroquinolones: Levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily for 10-14 days, providing excellent coverage against drug-resistant S. pneumoniae and β-lactamase-producing organisms 2, 6
  • Ceftriaxone: 1-2 g IM/IV once daily for 5 days (adults) or 50 mg/kg once daily (children) for patients unable to tolerate oral medications 2

Adjunctive Therapies

Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily should be added to antibiotic therapy in all patients, as they reduce mucosal inflammation and improve symptom resolution. 2, 1

Additional supportive measures include 2:

  • Analgesics (acetaminophen, NSAIDs) for pain and fever
  • Saline nasal irrigation for symptomatic relief
  • Adequate hydration

Short-term oral corticosteroids may be considered for patients with marked mucosal edema or who fail to respond to initial treatment. 2

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral rhinosinusitis—wait at least 10 days unless severe symptoms are present 2, 1
  • Do not use plain amoxicillin as first-line therapy given high prevalence (20-30%) of β-lactamase-producing organisms 1
  • Do not continue ineffective antibiotics beyond 3-5 days—failure to reassess and switch therapy leads to prolonged illness and potential complications 2, 1
  • Do not use azithromycin due to 20-25% resistance rates 2, 4
  • Reserve fluoroquinolones for treatment failures or severe penicillin allergy to prevent resistance development 2, 1

Expected Timeline for Improvement

Most patients should experience noticeable improvement within 3-5 days of starting appropriate antibiotic therapy. 2 If no improvement occurs by this timepoint, reassess the diagnosis and consider switching antibiotics. 2, 1 Approximately 90% of patients improve naturally within 7-15 days, with or without antibiotics. 2

References

Guideline

Acute Bacterial Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Microbiology and antimicrobial management of sinusitis.

The Journal of laryngology and otology, 2005

Guideline

First Line Antibiotic Treatment for Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.